This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Prix Lasker | |
|---|---|
| Name | Prix Lasker |
| Awarded for | Outstanding contributions to medical science and public health |
| Presenter | Lasker Foundation |
| Country | United States |
| Year | 1945 |
Prix Lasker is an annual set of awards recognizing excellence in biomedical research, clinical medicine, and public health, presented by the Lasker Foundation. The prizes have been associated with landmark discoveries, transformative therapies, and influential health policy initiatives, often prefiguring later recognition by institutions such as the Nobel Prize in Physiology or Medicine, the National Institutes of Health, and the Royal Society. Recipients range from bench scientists at the Howard Hughes Medical Institute and the Max Planck Society to clinicians at the Mayo Clinic and leaders at the World Health Organization.
The awards were established in 1945 by philanthropists Mary Lasker and Albert Lasker, connecting the prize to organizations including the Rockefeller Foundation, the Ford Foundation, and the Carnegie Institution for Science. Early recipients included figures associated with institutions like Harvard Medical School, Johns Hopkins Hospital, and the Pasteur Institute. Over decades the prizes intersected with major events such as the development of penicillin during World War II, the molecular biology revolution involving laboratories at the Cold Spring Harbor Laboratory and the Medical Research Council Laboratory of Molecular Biology, and public health campaigns led by the Centers for Disease Control and Prevention and the Pan American Health Organization.
The Prix comprises categories comparable to those used across scientific awards: basic biomedical research, clinical medical research, and public service or advocacy in health. Winners have been affiliated with organizations like the National Cancer Institute, Dana-Farber Cancer Institute, Salk Institute for Biological Studies, and the Wellcome Trust. Over time categories have reflected trends from the discovery of DNA structure tied to the University of Cambridge and the University of Oxford to immunotherapy advances at institutions such as the Dana-Farber Cancer Institute and the University of Pennsylvania Perelman School of Medicine.
A selection committee convened by the Lasker Foundation solicits nominations from academies and societies including the National Academy of Sciences, the American Association for the Advancement of Science, the American Medical Association, and international bodies such as the European Molecular Biology Organization. Committee deliberations include assessments of candidates' publications in journals like Nature, Science, and The Lancet, as well as patent portfolios registered with the United States Patent and Trademark Office and collaborations with centers like the Broad Institute. Final selections are announced at ceremonies often held in venues connected to the Columbia University medical community.
Recipients span pioneering molecular biologists, clinical trialists, and public health leaders including scientists associated with the Cold Spring Harbor Laboratory, leaders from the Bill & Melinda Gates Foundation, and Nobel laureates from the Karolinska Institute. Awardees have included investigators from the University of California, San Francisco, the Massachusetts General Hospital, the Stanford University School of Medicine, and contributors to major initiatives at the Billings Clinic and the Kaiser Permanente research divisions. Many laureates subsequently received honors from entities such as the Royal Society of London, the French Academy of Sciences, the Deutsches Krebsforschungszentrum, and the Japan Academy.
The awards have amplified profiles of work originating in laboratories at the Salk Institute, the Waksman Institute of Microbiology, and the Institut Pasteur, accelerating translational pathways toward regulatory interactions with the Food and Drug Administration and the European Medicines Agency. Recognition has facilitated funding from agencies like the National Institutes of Health and philanthropic support from the Howard Hughes Medical Institute and the Wellcome Trust, influencing careers at institutions including the University of Chicago Medicine and the Yale School of Medicine. The prize has shaped discourse within forums such as meetings of the American Society of Clinical Oncology and symposia at the Cold Spring Harbor Laboratory.
Critiques have arisen regarding perceived biases toward recipients affiliated with elite institutions such as Harvard University, the University of Pennsylvania, and the University of California system, and questions about transparency echo disputes seen in other awards administered by organizations like the Royal Society. Controversies have sometimes paralleled debates over intellectual property rights involving the United States Patent and Trademark Office and collaborations with industry partners including major pharmaceutical companies headquartered near the Pharmaceutical Research and Manufacturers of America offices. Debates have also referenced tensions similar to those in controversies involving the Nobel Prize and the Pulitzer Prize concerning recognition, equity, and the global distribution of scientific credit.
Category:Medical awards Category:Science and technology awards